Qi Chuang, Qin Xianxiong, Zhou Zuozhi, Wang Yan, Yang Qin, Liao Tianzhi
Department of Oncology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi 445000, Hubei, People's Republic of China.
Department of Breast Surgery, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi 445000, Hubei, People's Republic of China.
Cancer Manag Res. 2020 Nov 3;12:11169-11181. doi: 10.2147/CMAR.S272274. eCollection 2020.
Circ_0072995 is a novel identified circRNA and has been identified to involve in the metastasis of breast cancer. However, the detailed function and mechanism of circ_0072995 in the biological property of breast cancer cell remain vague.
The expression of circ_0072995, microRNA (miR)-149-5p and () mRNA was detected using quantitative real-time polymerase chain reaction. Western blot was used to detect the protein levels of , hexokinase-2 (HK-2), lactate dehydrogenase a chain (LDHA), and glucose transporter 1 (GLUT1). Cell proliferation, apoptosis, migration, and invasion were analyzed using cell counting kit-8 assay, flow cytometry, caspase-3 activity analysis, cell adhesion assay and transwell assay, respectively. Glucose metabolism was calculated by measuring glucose uptake, lactate production, and adenosine triphosphate (ATP) levels. The interaction between miR-149-5p and circ_0072995 or was confirmed by dual-luciferase reporter assay. In vivo tumorigenesis was performed using the murine xenograft model.
Circ_0072995 and were up-regulated in breast cancer tissues and cell lines, and knockdown of circ_0072995 or suppressed cell malignant properties and anaerobic glycolysis; importantly, overexpression attenuated the anticancer action of circ_0072995 knockdown in breast cancer. Besides, we also found circ_0072995 directly targeted miR-149-5p, thereby regulating its downstream gene by competitively binding to miR-149-5p. Additionally, xenograft analysis showed circ_0072995 silencing suppressed tumor growth via regulating and miR-149-5p in vivo.
This study demonstrated that circ_0072995 promoted cell malignant phenotypes and anaerobic glycolysis in breast cancer via up-regulating through sponging miR-149-5p, indicating a promising molecular target for breast cancer treatment.
Circ_0072995是一种新发现的环状RNA,已被证实参与乳腺癌的转移。然而,circ_0072995在乳腺癌细胞生物学特性中的具体功能和机制仍不清楚。
采用定量实时聚合酶链反应检测circ_0072995、微小RNA(miR)-149-5p和()mRNA的表达。蛋白质免疫印迹法用于检测()、己糖激酶-2(HK-2)、乳酸脱氢酶a链(LDHA)和葡萄糖转运蛋白1(GLUT1)的蛋白水平。分别采用细胞计数试剂盒-8法、流式细胞术、半胱天冬酶-3活性分析、细胞黏附试验和Transwell试验分析细胞增殖、凋亡、迁移和侵袭。通过测量葡萄糖摄取、乳酸生成和三磷酸腺苷(ATP)水平计算葡萄糖代谢。双荧光素酶报告基因试验证实了miR-149-5p与circ_0072995或()之间的相互作用。采用小鼠异种移植模型进行体内肿瘤发生实验。
Circ_0072995和()在乳腺癌组织和细胞系中上调,敲低circ_0072995或()可抑制细胞恶性特性和无氧糖酵解;重要的是,()过表达减弱了circ_0072995敲低对乳腺癌的抗癌作用。此外,我们还发现circ_0072995直接靶向miR-149-5p,从而通过与miR-149-5p竞争性结合来调节其下游基因()。此外,异种移植分析表明,circ_0072995沉默在体内通过调节()和miR-149-5p抑制肿瘤生长。
本研究表明,circ_0072995通过海绵化miR-149-5p上调(),促进乳腺癌细胞的恶性表型和无氧糖酵解,为乳腺癌治疗提供了一个有前景的分子靶点。